<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of a Single Domain Human Anti-Mesothelin Monoclonal Antibody for the Treatment of Human Cancers</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of a Single Domain Human Anti-Mesothelin Monoclonal Antibody for the Treatment of Human Cancers</h1>
    <p class="timestamp">Published: 2014-03-31 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive start-up option license to practice the inventions embodied in U.S. Patent Application 61/706,396 entitled "Mesothelin Antibodies and Methods for Eliciting Potent Antitumor Activity" [HHS Ref. E-236-2012/0-US-01], PCT Application PCT/US2013/059883 entitled "Mesothelin Antibodies and Methods for Eliciting ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2014-07022</p>
    <p><strong>Publication Date:</strong> 2014-03-31</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/03/31/2014-07022/prospective-grant-of-exclusive-license-the-development-of-a-single-domain-human-anti-mesothelin">https://www.federalregister.gov/documents/2014/03/31/2014-07022/prospective-grant-of-exclusive-license-the-development-of-a-single-domain-human-anti-mesothelin</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-07022</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
